PharmaCompass

fires off another lawsuit against a Lantus biosimilar
News Flash:- & ; Merck & Co.
has rushed to the defence of blockbuster basal insulin product Lantus in the once again, filing a patent infringement lawsuit against Merck & Co.
www.pharmacompass.com http://ow.ly/gIZE304psv9

siponimod hits targets in MS trial
News Flash:- Pharma AG
has unveiled further findings from a late-stage trial of its experimental multiple sclerosis BAF312 (siponimod), showing that the cut the risk of disability progression in adults with secondary progressive forms of the disease.
www.pharmacompass.com http://ow.ly/4uFq304prwC

Reddy's Expands Strategic Collaboration with Amgen
News Flash:- Reddys Laboratories; Amgen Inc
Reddy\'s Laboratories has announced that it has expanded its strategic collaboration with Amgen, one of the world\'s leading independent biotechnology companies, to market and distribute three of Amgen\'s medicines in India in the therapy areas of oncology and osteoporosis. Under the terms of the collaboration, Dr Reddy\'s will commercialise XGEVA(denosumab), Vectibix (panitumumab) and Prolia (denosumab) in .
www.pharmacompass.com http://ow.ly/3V7I304pqwm

.S. FDA approves Bayer contraceptive device Kyleena
News Flash:- & Pharma AG
.S. and Administration approved Bayer AG\'s hormonal contraceptive device, Kyleena, to prevent pregnancy for up to five years, the German company said on Monday.
www.pharmacompass.com http://ow.ly/2PMn304pqbk

Comments On Discount And Rebate Program For Nitropress And Isuprel
News Flash:- , Isuprel & Pharmaceuticals International, Inc.
#(DRL) has expanded its strategic collaboration with -based independent biotechnology firm Amgen to market and distribute in three of latter\'s medicines, used in the therapy areas of oncology and osteoporosis.
www.pharmacompass.com http://ow.ly/6izk304kzp1